Inventor · name-matched record
KLEIN CHRISTIAN
1 granted patent·11 pending applications·0 citations·filing 2023–2025
13Inventor score
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
12 records- 0185US2026022172A1Bispecific t cell activating antigen binding moleculesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0281US2026055184A1Protease-activated t cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0379US2026098095A1Antibodies binding to hla-a2/mage-a4HOFFMANN LA ROCHE INC·Filed 2025·Application pending·0 cites
- 0478US2026053917A1Treatment methodHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0575US2026083855A1ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0672US2026015436A1Antibodies for chelated radionuclidesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0771US2026091062A1Recombinant Fc domain - IL2 variant polypeptides and combination therapy with membrane-anchored antigen binding polypeptidesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0870US12565530B2Combination therapy with targeted 4-1BB (CD137) agonists/anti-FAP binding domain and anti-CEA/anti-CD3 bispecific antibodyHOFFMANN LA ROCHE·Filed 2023·Granted Mar 3, 2026·0 cites·9 claims
- 0967US2026049160A1Tetravalent multispecific antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1061US2026085113A1All-in-one agonistic antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1156US2026062485A1Antigen binding moleculesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1251US2026035462A1Protease-activatable t cell bispecific antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KLEIN CHRISTIAN files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →